• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9551
Device Problems Obstruction of Flow (2423); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Thrombosis/Thrombus (4440); Restenosis (4576)
Event Date 02/18/2023
Event Type  Injury  
Event Description
Promus premier china registry.It was reported that a myocardial infarction and restenosis occurred.In (b)(6) 2019, the subject presented with unstable angina (braunwald classification- unknown) and was referred for cardiac catheterization.The target lesion was located in the proximal right coronary artery (rca) extended up to middle rca with 80% stenosis and was 20 mm long, with a reference vessel diameter of 4.00 mm.The target lesion was treated with pre-dilatation and placement of a 4.00 mm x 24 mm promus premier stent system.Following post dilatation, the residual stenosis was noted to be 0%.The subject was discharged on aspirin and clopidogrel.In february 2023, during follow-up visit the subject was diagnosed with acute myocardium infarction and was hospitalized on the same day for further evaluation and treatment.In the same day, the subject was referred for coronary angiography which revealed that the unknown % stenosis noted in proximal rca.The unknown % stenosis noted in proximal rca which had previously placed study device was treated with percutaneous coronary intervention.Post procedure, percent diameter stenosis was noted to be 0%.Additionally, medications were adjusted to treat the event.In june 2023, the event was considered to be recovered/resolved and the subject was discharged on the same day on aspirin and clopidogrel.
 
Event Description
Promus premier china registry it was reported that a myocardial infarction and restenosis occurred.In march 2019, the subject presented with unstable angina (braunwald classification- unknown) and was referred for cardiac catheterization.The target lesion was located in the proximal right coronary artery (rca) extended up to middle rca with 80% stenosis and was 20 mm long, with a reference vessel diameter of 4.00 mm.The target lesion was treated with pre-dilatation and placement of a 4.00 mm x 24 mm promus premier stent system.Following post dilatation, the residual stenosis was noted to be 0%.The subject was discharged on aspirin and clopidogrel.In february 2023, during follow-up visit the subject was diagnosed with acute myocardium infarction and was hospitalized on the same day for further evaluation and treatment.In the same day, the subject was referred for coronary angiography which revealed that the unknown % stenosis noted in proximal rca.The unknown % stenosis noted in proximal rca which had previously placed study device was treated with percutaneous coronary intervention.Post procedure, percent diameter stenosis was noted to be 0%.Additionally, medications were adjusted to treat the event.In june 2023, the event was considered to be recovered/resolved and the subject was discharged on the same day on aspirin and clopidogrel.It was further reported that the subject experienced proximal stent thrombosis and was diagnosed with acute myocardial infarction in february 2023.The location of myocardial infarction was anterior (septal) and was not identifiable.
 
Event Description
Promus premier china registry it was reported that a myocardial infarction and restenosis occurred.In (b)(6) 2019, the subject presented with unstable angina (braunwald classification- unknown) and was referred for cardiac catheterization.The target lesion was located in the proximal right coronary artery (rca) extended up to middle rca with 80% stenosis and was 20 mm long, with a reference vessel diameter of 4.00 mm.The target lesion was treated with pre-dilatation and placement of a 4.00 mm x 24 mm promus premier stent system.Following post dilatation, the residual stenosis was noted to be 0%.The subject was discharged on aspirin and clopidogrel.In (b)(6) 2023, during follow-up visit the subject was diagnosed with acute myocardium infarction and was hospitalized on the same day for further evaluation and treatment.In the same day, the subject was referred for coronary angiography which revealed that the unknown % stenosis noted in proximal rca.The unknown % stenosis noted in proximal rca which had previously placed study device was treated with percutaneous coronary intervention.Post procedure, percent diameter stenosis was noted to be 0%.Additionally, medications were adjusted to treat the event.In (b)(6) 2023, the event was considered to be recovered/resolved and the subject was discharged on the same day on aspirin and clopidogrel.It was further reported that the subject experienced proximal stent thrombosis and was diagnosed with acute myocardial infarction in (b)(6) 2023.The location of myocardial infarction was anterior (septal) and was not identifiable.It was further reported that the 100 % stenosis noted in proximal rca in (b)(6) 2023.The location of mi was not identifiable, and it is unknown whether it was q-wave or non-q-wave.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17573940
MDR Text Key321450201
Report Number2124215-2023-42043
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9551
Device Catalogue Number9551
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age44 YR
Patient SexMale
-
-